Literature DB >> 24769598

Herpes simplex virus-related oral mucositis in patients with lymphoma.

Maria D Guerrero1, Karen K Swenson2.   

Abstract

A 58-year-old man named J.S. was diagnosed with non-Hodgkin lymphoma and underwent treatment with standard rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy. He presented to his local outpatient clinic for evaluation and laboratory tests on day 10 after cycle 3. During this visit, J.S. reported great difficulty opening his mouth with significant gingival and lingual pain when eating and drinking in spite of prophylactic oral care. Laboratory test results revealed a white blood cell count of 0.9 k/ul, hemoglobin level of 8.9 g/dl, platelets of 100 k/ul, serum creatinine level of 1 mg/dl, and blood urea nitrogen level of 29 mg/dl.

Entities:  

Keywords:  herpes simplex virus; immunocompromised patients; lymphoma; oral mucositis

Mesh:

Substances:

Year:  2014        PMID: 24769598     DOI: 10.1188/14.ONF.327-330

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  2 in total

Review 1.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

2.  Herpetic tracheitis in association with rituximab therapy.

Authors:  Lorraine Thong; Barry J Plant; Julie McCarthy; Desmond M Murphy
Journal:  Respirol Case Rep       Date:  2016-05-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.